MariMed Inc. Price & Performance (MRMD)

I'm very proud of the team that we've built and the success we have achieved in continually growing market share for all of our brands. I am honored to kick off today's first quarter earnings for 2025. Joining the call today are John Levine, our Chief Executive Officer Mario Pinno, our Chief Financial Officer and Ryan Cranell, our chief commercial officer. This call will be archived on our Investor Relations website and contains forward looking statements. Actual events, or results may differ materially from these forward looking statements and are subject to various risks and uncertainties. A discussion of some of these risks is in the Risk Factors section of our 10 ks available on our website. Any forward looking statements reflect management's expectations of today, and we assume no obligation to update them unless required by law. Additionally, we will refer to certain non GAAP financial measures, which are reconciled in our earnings release. I will now turn the call over to John for his first quarter overview.

Thank you, Kevin. For the hard work you and your team are doing to help us become a leading cannabis CPG company. And good morning, everyone. Thank you for joining us today. Last night, we reported our Q1 results. Our revenue for the quarter was essentially flat versus the same period last year. Despite a dynamic environment, I continue to believe everything we're doing today to build a brand powerhouse will ultimately deliver the enhanced shareholder value our investors demand and deserve. Our brands continue to capture more share across the markets we serve And we sold them into 70 new storefronts in the quarter. As a result, our wholesale revenue grew year over year sequentially and as a percentage of our overall business. Wholesale now accounts for 44% of our revenue mix. Up from 42% sequentially. That's been our strategy and we expect to see the percentage continue to climb as we further leverage our brands as a primary growth engine for the company. Executing that plan to increase wholesale sales is resulting in short term impact on our financial performance that I wanted to discuss. We've always said that the ultimate winners in cannabis will be the companies with the most trusted and best selling brands.

I'm very proud that we're well on the way towards that goal.

We're confident that ultimately our strategy will pay off with similar gross margins of 45% plus. Like traditional CPG companies such as P and G, or Coca Cola deliver. To get there, we need two things to happen.

First, need greater scale.

Both at wholesale and selectively at retail. That's our focus right now in I'll share what we're doing in a minute to keep expanding our brand distribution. Second, we need legislative reform that will enable significant operating efficiencies for companies like ours that will come with interstate commerce, e commerce, and other benefits. In advance of these catalysts, our margins are likely to lag behind other MSOs for the simple reason that they have a much larger retail footprint. The way we see it though, the pendulum is going to swing in the other direction. With our strong wholesale performance, we were able to partially offset a soft quarter at our retail stores Pricing pressures across all markets new competition in Illinois, and the general economic uncertainty all contributed We're mitigating the impact through a series of pricing marketing, cost reduction strategies to encourage more transactions. Drive customer loyalty and support margin expansion. Ryan will provide more detail in his remarks. We're confident these initiatives will pay off over the long term when consumers confidence returns. An area where we couldn't be prouder is how we're doing in supporting the people in the communities we serve. Our in house brands help on the home front program is a great example Through the program, we raised visibility about the challenges our nation's veterans face.

In dealing with their housing costs. The issue has never been as important as right now. Given the state of the economy.

We're thrilled to award thousands of dollars to worthy veterans to help defray the cost of their home expenses. And we're looking to build on the program later this year. Speaking of the economy, let me spend a minute on tariffs. And their impact on our business For the short term, we shouldn't see any significant impact. Beyond that, we're monitoring tariffs like everyone else in assessing in real time. How to approach the rest of the year. For example, we're looking at alternative suppliers for certain inputs and hardware. That's the disciplined approach that has been the cornerstone of how we've always operated the business It's what has allowed us to grow Marimed while maintaining a strong balance sheet. It's that same approach and our strong balance sheet that enable us to implement two key strategic initiatives that will fuel long term growth and profitability. The first is what I call expand the brand. Which involves continuing to make our brands accessible to as many people as we can in both existing markets and new markets.

It starts with investing in innovation to create additional new products that meet the needs of today's increasingly sophisticated cannabis consumer. Brian is going to share details of a product we're launching in the next few weeks. And we're very excited about it. Creating the product is half the battle The other half is selling it. Our brands are already top sellers. But there's significant opportunity to seize additional share we believe, that more effectively align sales, marketing, operations will help us make it happen. Brian's recent all well deserved promotion to Chief Commercial Officer is a key to that effort. As far as new markets are concerned, we continue to be in M and A discussions with a number of operators to acquire assets that would enable us to immediately and profitably distribute our brands in new high growth states We're making meaningful progress and I'm hopeful we'll have something more definitive to share in the month to come. The goal of any acquisition is to integrate the operation as seamlessly as we have with First State Compassion in Delaware. We completed that transaction on March 1, Our teams have been working together as we get ready for adult use sales which we expect to commence this year.

We're also looking to enter new markets through licensing [indiscernible] We have been negotiating with potential partners in several states where we're confident our brands can capture significant market share. The second initiative we're focused on to fuel our long term growth and profitability involves identifying new sources of revenue We can't just keep waiting for the federal government to help our industry anymore. We know reform will happen eventually. But eventually, it's not a growth strategy. So we're taking charge Our team is assessing our best options to enter the hemp space. With our strong brand recognition, and performance, consumers throughout the country tell us they like to buy our products in their states. So we believe entering the hemp space will help us generate new revenue while staying focused on our strategy of expanding our brand distribution into new storefronts. The key for us will be to make it happen without taking the eye off the ball of our core business. I will now turn the call over to Ryan for his update. Thanks, John, and good morning, everyone.

As John said, wholesale penetration and the power of our brands continue to be the lead story for us. On our last earnings call, said our brands are the moat surrounding our business. Well, the moat got a little wider during the first quarter. Let me give you some highlights. Missouri is off to a very nice start for us with Betty's, Bubby's and Vibations entering the quarter in nearly 50 storefronts. Reciprocity is a real challenge in that market. So without any dispensaries of our own to buy our customers products, it's been the incredible reputation of our brands that opened doors for us. In Illinois, sold our products into more than 180 stores during the quarter. Which was a 5% increase sequentially and 46% year on year. All of the brands are performing well there. Although Betty's continues to be our lead horse in terms of volume. Betty's is now number five, up from number seven last quarter. That's not our only success in Illinois, though. Vibations has climbed to the number six brand and beverages and Bubbies to number two in baked goods. Keep in mind that this success was achieved in just over a year in a very mature Illinois market.

Nature's Heritage flower hit shelves right after the quarter closed. So it's too early to provide market data. What I can tell you is that testing of the product has been very strong. And consumer feedback has been terrific. In Massachusetts, we saw modest growth in wholesale in a market that seems to have stabilized for us. Our brands continue to have strong penetration in the state with our products in 71% of nearly 400 dispensaries. Our brand share is equally strong. Betty's remains the number one edible in Massachusetts. And our other brands are doing great as well. Bobby's is number three among baked goods. And vibrations is number seven among beverages. In Maryland, we've hit the trifecta with Betty's, Bubbies, Vibations all number one in their respective categories. For that matter, Betty's remains the number one edible in Delaware as well. Turning to our dispensaries, the way we look at it, we're in a long game. As John said, we're doing everything we can to deliver an exceptional customer experience in the face of today's market challenges and we believe our initiatives across pricing, marketing, and operations are working to offset the impact. We're buying smarter. Which has enabled more competitive pricing options for our customers as well as a decrease in days on hand inventory.

We've streamlined our labor in strong alignment with customer traffic data. And we've unified and enhanced our customer loyalty program across all our markets. Looking forward, we're excited about some of the positive things that are happening as far as new regulations in some of our markets. That should provide us opportunities to grow our retail sales. For instance, Marillyn just announced that they're going to allow public cannabis events. Our Annapolis store has a great space to host such events. In Massachusetts, where home delivery has continued to gain traction as an option for our retail customers, a new regulation will enable us to have one driver in our delivery vehicles rather than two. We'll be able to put that cost saving into putting another vehicle on the road. I'm also really excited about the innovative new products we're bringing to the market. Our Betty's Eddie Caramel Shoe that we recently launched in Massachusetts is selling very well. Next up is an entirely new product format for us. In the next few weeks, we're launching a brand that takes advantage of the fast growth of functional mushrooms that we're seeing in the traditional CPG space. It's called microdose by Nature's Heritage, will come in a convenient pill form that's vegan.

Don has instilled in the company the mantra that we are going to win by becoming the leading consumer packaged goods company in cannabis. That is a highly achievable goal given the performance of our current portfolio. There are significant opportunities to continue growing market share as we push the envelope on innovation marketing, and execution. That concludes my update.

I'll turn the call over to Mario. Thank you, Ryan, and good morning, everyone.

Last night, we reported first quarter revenue of $38,000,000 which was flat year on year and decreased sequentially 2.7% from 39,000,000 The sequential drop was due to an expected seasonal impact partially offset by one month of revenues from FSC we acquired effective March 1.

Wholesale gross revenue increased 16% versus the prior year quarter and 4% sequentially, driven by increased market penetration as Ryan noted. Overall, retail revenue was down 7% versus the prior year period, due to the market challenges that John and Ryan alluded to earlier.

On a gross revenue basis, 44% of our q one sales were derived from the wholesale business in keeping with our planned focus on building our brand distribution. Over the past four quarters, wholesale share of product revenue has increased from 38% to 44%, as we continue to leverage our brands to enter more doors in existing markets and enter new markets. As John explained, this is a planned shift in our strategic focus will naturally dilute margins. But we are mitigating the impact through product mix management and SKU rationalization. Optimizing supply chain and sourcing, and implementing operational efficiencies and automation. Non GAAP adjusted gross margin for the first quarter was 41.3%, which was down from 43.8% in the same period last year, and 43.3% in the prior quarter. The decline in gross margins was primarily driven by price compression along with ramp up of costs related to our new cultivation facilities in Illinois and our new processing facility in Missouri. In Missouri, especially, market entry has been slower due to reciprocity challenges in a nascent market where we recognized our first sale in December 2024. The company incurred a net loss of 5,400,000.0 during the quarter. This compares to a net loss of $1,300,000 in the same period last year and $8,300,000 last quarter.

Total operating expenses for the first quarter were $16,000,000 or 42% of revenue compared with 14,500,000.0 or 38% of revenue last year. The increase was due to a one time write off of miscellaneous receivables related to our retail business. Operating expenses, excluding intangible amortization, one time deal costs, and stock based compensation, 14,900,000.0 compared to $13,900,000 in the first quarter of last year.

The increase year on year is mainly attributable to the one time receivable write off noted previously. If we exclude this write off, approximately 100 basis points of the sequential decrease is due to a one month of FSC's operations, offset by cost saving initiatives and further steps to streamline operations we commenced in the latter part of 2024. Adjusted EBITDA in Q1 was 2,600,000.0 down from the $4,700,000 a year ago and 5,900,000.0 in Q4. This decrease was due to lower gross profit converting through to the bottom line and higher compensation and benefit costs associated with higher headcount attributable to new assets in Illinois, Missouri, and Delaware.

And the one time write off of a receivable balance.

In response, disciplined expense management remains a top priority as we navigate today's challenging environment and we continue to look for opportunities to reduce our cost structure throughout the company. Turning to the balance sheet and cash flow.

We maintained a strong balance sheet ending the quarter with $7,200,000 in cash and cash equivalents, and $2,700,000 in working capital. We had no significant capital expenditures during the quarter, as major build outs were completed by the end of twenty twenty four. We generated $1,300,000 in cash flow from operations versus the $3,200,000 in the same period last year. Turning now to Q2. Based on our visibility today, we anticipate an increase in second quarter revenue to be in the high single digits compared to Q1. We anticipate the increase to be driven by a full quarter of FSC revenues modest contributions from our promotional activities, and continued wholesale door ads. At the same time, we anticipate continued softness in retail. That concludes our financial review. I will now turn the call over to John for his concluding remarks.

Thank you, Mario. Before turning the call over to the operator, I want to address our shareholders.

Like our shareholders, we are frustrated that the public markets continue to lag behind the intrinsic value of Marimed. Not a matter of [indiscernible] it's only a matter of when that turns around. This is a long game and we've built a very strong foundation to position the company as a thriving industry leader for a long time to come.

It's not hyperbole when I say we're driving towards building the best CBG company in cannabis. And our innovation will continue to drive new brands to meet market opportunities.

The best days for Marimed are in front of us. Finally, I'd like to thank our Marimed employees for their dedication to improve the life of our patients and customers every day. Operator, open the lines for questions.

Thank you. Please be prepared to ask your question when prompted. Once again, if you have a question, please press 1 on your phone now. One moment while we prepare our Q and A roster. First question comes from the line of Anders Semple from Ventum Financial. Your line is now open.

Good morning. Thanks for taking my questions. So first one, just a housekeeping item. The prepared remarks, you mentioned a revenue increase in the high single digits in the second quarter. Just want to clarify whether that's on a quarter on quarter basis or a year over year basis.

Hi, it's Mario. It's a quarter over quarter basis.

And most of the driver of that sorry?

Oh, I said, great. That's helpful.

Okay.

I'll move on.

So the latest expectations in Delaware, I'd love to hear what your hearing from that state in terms of first adult use sales in that market when we might expect to see that launch. Morning Andrew. Thank you for joining the call. Thank you for the question. Delaware has finally found a lead of the cannabis program and we are told it could be a timing of anywhere from sixty to one hundred and twenty days before we see the first rec store open.

Great. And then just on the bad debt expense in the quarter, there is the receivable balance that was written off. Maybe just would appreciate some more color into that. Whether you think that's going to be a one time item for the year or given some of the balance sheet challenges we're seeing across the industry, whether there's the risk that that might be something we could see again. Later in the year. Just want to get some thoughts around that and how you're managing that risk.

Hi, Andrew. It's Mario here. Yes. That is a one time item. I want to clarify, it does not relate to our trade receivables. It relates to a a a receivable from a vendor that, we to put a reserve up against. We're obviously pursuing all actions to collect the funds. And I think we ultimately will prevail, but for right now, we've put a reserve up against that balance.

Great. That's it for me. I'll get back into queue. Thanks again.

Your next question is from the line of Pablo Zuanic from Zuanic and Associates. Please ask your question.

Thank you. Good morning, everyone. It looks first question was on the area of innovation.

You talked about these new hemp products I don't know how much you can share with us right now, but are we talking about hemp drinks? Are we talking about Betty's hemp derived gummies? If you can give more color on the products you are thinking about and the distribution, just e commerce, you know, through your own dispensaries only, but also through C stores, gas stations, and other outlets. And by the same token, same question in terms of microdose, very interesting product. You said functional mushrooms, so we are not talking about psychedelics, I suppose. How wide distribution? Could you say that whole food and other places? Or is this just something you want to sell at your dispensaries only? Thanks.

Morning, Pablo. This is John. Thank you for joining the call.

Yes, what I stated in the in the reading was that I was making the mention that we're looking at all aspects to grow the business as our brands are very successful in that hemp is another direction for adding additional revenue.

We're looking at all aspects. Our brand recognition is already there with our brands We are looking beverage and other lines, but we haven't made the final decision on what we're doing fully in the hemp yet. We're looking at making sure we make the decision that's best for the company without hurting our cash flow or earnings. As far as the microdose, I'm gonna let Ryan speak about that.

Sure, thanks for the question, Pablo. I'm very excited about Microdose. Microdose will not just be in Panacea stores. So that will be widely distributed product across all our states. So very excited to bring Microdose to market. We feel We feel it is an innovative product in the market. 1906 has had its day and done a really good job of showing that people will consume cannabis through a pill form. And I think we're innovating beyond what 1906 has done here. So we're really grabbing on to what we see as a trend in CPG around functional mushrooms. Bringing effects based functional mushrooms to bear within the product and it's a vegan product that's calorie free. So we feel really confident that's made really well and that it's to perform really well. Yeah. Actually it's it's shelves it's shelves this weekend actually in Mass Right. And when you said Ryan, in all your states, but I would still be in dispensaries, right? Third party dispensaries? Or are you thinking of other non cannabis outlets?

So, Pablo, I think that plays into the whole hemp strategy that John mentioned. So that's still under evaluation. Think the real headline there is we're looking at every opportunity to expand our brands.

Okay. Understood. And then on the same topic, I think you've mentioned the opportunity for licensing your brands, especially Betty's. New York, it's a fast growing market. How do you think about that? Or do you always want to have control over the chain and control your operation in the markets that you operate? Or for example, with New York, licensing to someone there, Betty's, would that make sense? How do you think about that?

Pablo, good question. Thank you very much for asking. We have been working with other vendors in New York. We have a that we applied for well over a year ago, still waiting for word on that. But in the meantime, we are in discussions with a few groups in New York and other states to bring our Betty's and our other products to that state or to other states.

That's just another avenue for additional revenue. We're not against finding it but it's finding the right partner that will put the dedication and time into doing what our SOPs require.

Okay, thank you, Lugan. Just two more, two last questions. One, just an update on the second Maryland store. Think you closed on the acquisition. Is it open? Are you going to move the store? What can you how is it doing? Can you share any color on that? And then separately, maybe try to help us quantify the upside from Delaware right? You your estimates of the current size of the medical market, I think there's only seven stores. It would take a while for new licensees to open stores. So that could be a great opportunity there. But any tools you can give us to quantify the upside from Delaware. I realize it's a small state, only seven stores, that should mean relevant upside. Thank you.

Our Upper Marlboro store in Maryland continues to grow every month and we're very excited about how well it's doing and we continue to see positive there.

In Delaware, yes, there presently is only seven stores, but have already issued several adult use licenses to social equity people that have started to build out their locations even though there's a delay. On the final licensing. So we're hopeful that our wholesale business will be able to start shipping earlier than later. As I said, you're looking at sixty to one hundred and twenty days before they'll have that up and running.

But we are ready. We're excited and ready to go.

With all of our brands plus some additional brands that First Aid had already down there. Yeah, and Pablo, just a dovetail on John's answer, we have relationships with all open stores today.

And our team is actively creating relationships with all the stores to open. Doing that ahead of time. So we're well positioned when the stores do open. That's great. Thank you.

Your next question comes from the line of Joe Gomes from NOBLE Capital. Please ask your question.

Good morning.

Wanted to start off, you mentioned that Missouri seems to have been a little bit more challenging than expected and was wondering if you provide a little more color and detail there.

Sure, Joe. Thank you for the question. This is Ryan Crandall. I would say, Missouri is a market that doesn't have a ton of companies that operate outside of Missouri, so they're localized operators. And those localized operators, as that market has grown, have created a network amongst themselves that they buy and sell products from each other and they have full menu. So as new folks come into that market, there's don't want to say a protected menu at each location, but there's a good amount of breakthrough that has to happen. And there's you're not just breaking onto their shelves, you're breaking into a category that they're already sharing with someone else. So I think some of that what you hear reciprocity in the cannabis markets, I think it's very strong in Missouri. But I mean, I do think we see that ultimately brands and great brands and great products do win the day. And we are getting into more and more stores every month. So that is the name of the game and then once we get into the doors, how do we expand and then how do we support the highest level of velocity that we can.

So we have great teams, great processes to do all that. So I'm very confident that we're going to be able to continue to grow in Missouri.

Okay, thanks for that color.

And then just looking at you know, the the income statement, marketing and promotion was down pretty significantly. [indiscernible] you know, year over year. I was just wondering, was something unusual in the first quarter of last year or What is behind the decline there?

The marketing and promotion spend?

Joe, it's Mario here. I guess as we're looking at our operating expenses, obviously, we're being a lot more thoughtful in smart in terms of where we're spending our dollars. So that's purely just a reduction in more of our programmatic marketing. We're focusing more like localized marketing. And that's probably why you see the decrease in the dollar. There. Okay. Let's see. Was there think I had one more here. [indiscernible] that.

Oh, on in Ohio, I know you had talked about possibly getting another retail location. Obviously, you'd like to get the full integrated operations there. I wonder if can give us a little more of an update where things stand in Ohio.

Hey, Joe, John Levine, thank you for joining the call today. In Ohio, we have been looking for real estate and it has to be in an area where you can get support from the local community. And with all the setback requirements and everything else, and also whether we buy or we lease, those things come into making it a little bit difficult because of all the limitations with cannabis still even with local government saying yes and no, but more importantly, bank that we get our mortgages from, making sure that they're gonna be fully comfortable with the valuation. We do have several people looking, and we've looked at a couple, lost the few bids. But we're hopeful that we can get something done before the end of the year.

Great. Thanks for that. I'll get back in queue.

There are no further questions at this time. This concludes today's conference call. Thank you for your attendance.